Literature DB >> 25486187

Molecular mechanisms orchestrating cyclin stability.

Yongxing Gong1, Timothy A Chan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25486187      PMCID： PMC4614406          DOI： 10.4161/15384101.2014.946376

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.

Authors:  Yongxing Gong; Travis Ian Zack; Luc G T Morris; Kan Lin; Ellen Hukkelhoven; Radhika Raheja; I-Li Tan; Sevin Turcan; Selvaraju Veeriah; Shasha Meng; Agnes Viale; Steven E Schumacher; Perry Palmedo; Rameen Beroukhim; Timothy A Chan
Journal:  Nat Genet       Date:  2014-05-04       Impact factor: 38.330

2.  Genetic reevaluation of the role of F-box proteins in cyclin D1 degradation.

Authors:  Tomoharu Kanie; Ichiro Onoyama; Akinobu Matsumoto; Masanori Yamada; Hirokazu Nakatsumi; Yuki Tateishi; So Yamamura; Ryosuke Tsunematsu; Masaki Matsumoto; Keiichi I Nakayama
Journal:  Mol Cell Biol       Date:  2011-11-28       Impact factor: 4.272

3.  Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line.

Authors:  H Strohmaier; C H Spruck; P Kaiser; K A Won; O Sangfelt; S I Reed
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

4.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

5.  Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Authors:  Douglas I Lin; Olena Barbash; K G Suresh Kumar; Jason D Weber; J Wade Harper; Andres J P Klein-Szanto; Anil Rustgi; Serge Y Fuchs; J Alan Diehl
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

6.  Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Authors:  Selvaraju Veeriah; Barry S Taylor; Shasha Meng; Fang Fang; Emrullah Yilmaz; Igor Vivanco; Manickam Janakiraman; Nikolaus Schultz; Aphrothiti J Hanrahan; William Pao; Marc Ladanyi; Chris Sander; Adriana Heguy; Eric C Holland; Philip B Paty; Paul S Mischel; Linda Liau; Timothy F Cloughesy; Ingo K Mellinghoff; David B Solit; Timothy A Chan
Journal:  Nat Genet       Date:  2009-11-29       Impact factor: 38.330

Review 7.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.